ADMP - アダミス・ファ―マス―ティカルズ (Adamis Pharmaceuticals Corporation) アダミス・ファ―マス―ティカルズ



symbol ADMP
会社名 Adamis Pharmaceuticals Corp. (アダミス・ファ―マス―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company''s product portfolio includes specialty pharmaceutical products such as Epinephrine pre-filled syringe (PFS) APC-5000 dry powder inhaler (DPI) APC-1000 and APC-2000 and biotechnology products such as TeloB-VAX (vaccine) APC-100 APC-200 and APC-300. The Company''s lead product candidate the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe or the Epinephrine PFS is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.   アダミス・ファ―マス―ティカルズは米国の医薬品会社。アナフィラキシ―(急性の全身過敏症)、喘息、慢性閉塞性肺疾患、アレルギ―性鼻炎治療のネピネフリン自己注射剤、ドライパウダ―吸入器、吸入ステロイド薬の治験を行う。また、前立腺がんのテロメラ―ゼ阻害剤を治験中。本社はカリフォルニア州サンディエゴ。   Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
本社所在地 11682 El Camino Real Suite 300 San Diego CA 92130 USA
代表者氏名 Richard C. Williams リチャード・C・ウィリアムズ
代表者役職名 Independent Chairman of the Board
電話番号 +1 858-997-2400
設立年月日 32660
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 126人
EBITDA EBITDA(百万ドル) -28.29893
終値(lastsale) 3.09
時価総額(marketcap) 146130296.22
時価総額 時価総額(百万ドル) 144.23860
売上高 売上高(百万ドル) 13.32986
企業価値(EV) 企業価値(EV)(百万ドル) 145.65953
当期純利益 当期純利益(百万ドル) -22.70772
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Adamis Pharmaceuticals Corp revenues increased 4% to $7.1M. Net loss increased 61% to $17.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $2.7M to $7.1M (expense) Selling general_administrative expense increase of 14% to $12.8M (expense).



   Adamis shares slump as FDA declines to approve opioid overdose treatment  2019/11/25 13:25:28 Channel NewsAsia
REUTERS: Adamis Pharmaceuticals Corp said on Monday the U.S. Food and Drug Administration declined to approve its opioid overdose treatment, …
   FDA declines to approve Adamis Pharma's Zimhi to treat opioid overdose  2019/11/25 13:12:07 Reuters
Adamis Pharmaceuticals Corp said on Monday its opioid overdose treatment was rejected by the U.S. Food and Drug Administration.
   Adamis Pharmaceuticals (NASDAQ:ADMP) Stock Price Down 6.1%  2019/11/13 05:30:53 Modern Readers
Shares of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) dropped 6.1% during trading on Tuesday . The company traded as low as $0.88 and last traded at $0.92, approximately 2,118,300 shares changed hands during trading. An increase of 199% from the average daily volume of 709,350 shares. The stock had previously closed at $0.98. ADMP has been the […]
   Adamis Pharmaceuticals (NASDAQ:ADMP) Shares Gap Down to $0.89  2019/11/08 21:46:10 Modern Readers
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares gapped down before the market opened on Friday . The stock had previously closed at $0.88, but opened at $0.89. Adamis Pharmaceuticals shares last traded at $0.95, with a volume of 81,754 shares traded. A number of equities analysts recently weighed in on the stock. Zacks Investment Research upgraded shares […]
   Could The Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Ownership Structure Tell Us Something Useful?  2019/10/18 10:26:52 ACI Information Group
A look at the shareholders of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) can tell us which group is most…
   Adamis Pharmaceuticals' (ADMP) CEO Dennis Carlo on Q1 2019 Results - Earnings Call Transcript  2019-05-10
Adamis Pharmaceuticals Corporation (ADMP) Q1 2019 Results Earnings Conference Call May 9, 2019 5:00 PM ET Company Participants Dennis Carlo President and Chief Executive Officer Rob Hopkins Chief Financial Officer Ronald Moss Chief Medical Officer Dav…
   Adamis Pharmaceuticals Is Poised For A Sharp Rebound  2019-04-25
Source: BigCharts Long-suffering shareholders have seemingly thrown in the towel on Adamis ( ADMP ) - again! When will they ever learn? Just over the past year, ADMP has fallen and rebounded many times (see my earlier article) . Interestingly, the stock penetrated a lower technical suppor…

 関連キーワード  (医薬品 米国株 アダミス・ファ―マス―ティカルズ ADMP Adamis Pharmaceuticals Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)